Will all newborns receive Whole Genome Sequencing at birth?  How fast will Direct to Consumer Testing grow?  What sequencing technology will take the lead? What’s holding the industry back?

A plummeting of costs for Whole Genome Sequencing (WGS) is creating a gold rush for market players.  New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.  The report forecasts the market size out to 2022.  The report includes detailed breakouts for 14 countries and 5 regions for Germline, Somatic, Pathogen, Direct to Consumer and Agricultural markets.

Germline? Somatic? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon.  What are the issues?  Find the opportunities, and the pitfalls.  Understand growth expectations and the ultimate market forecasts for the next five years.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. 

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.   

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School